The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro

被引:10
|
作者
Yamaguchi, Masayoshi [1 ]
Levy, Robert M. [2 ]
机构
[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, C-5054,1365 C Clifton Rd NE, Atlanta, GA 30322 USA
[2] Primus Pharmaceut Inc, Dept Clin Dev, Scottsdale, AZ 85253 USA
关键词
beta-caryophyllene; baicalin; (+)-catechin; curcumin; cell proliferation; apoptosis; RAW267.4; cells; macrophage; HEPATOMA H4-II-E CELLS; EXPRESSION; OVEREXPRESSION; INVOLVEMENT; ALPHA; PAIN;
D O I
10.3892/ijmm.2016.2801
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
beta-caryophyllene, which is a constituent of many essential oils, has been known to be a selective agonist of the cannabinoid receptor type-2 and to exert cannabimimetic anti-inflammatory effects in animals. The effects of beta-caryophyllene on macrophages have not been investigated to date. This study was undertaken to determine whether beta-caryophyllene exerts suppressive effects on mouse RAW267.4 macrophages in vitro in comparison with other botanical molecules that exert antioxidant and anti-inflammatory effects. The proliferation of RAW267.4 cells was suppressed by culture with beta-caryophyllene (50; 100 and 200 mu g/ml of medium) or curcumin (100 and 200 mu g/ml). Culture with baicalin (1-200 mu g/ml) or (+)-catechin (1-200 mu g/ml) did not exert an effect on RAW267.4 cells. The combination of beta-caryophyllene (1 or 10 mu g/ml) with either curcumin (1 or 10 mu g/ml), baicalin (1 or 10 mu g/ml) or (+)-catechin (1 or 10 mu g/ml) did not exert any suppressive effects on cell proliferation. Of note, the combination of all three agents, beta-caryophyllene, baicalin and (+)-catechin at the concentration of either 1 or 10 mu g/ml was found to exert synergistic suppressive effects on cell proliferation. Moreover, the combination of beta-caryophyllene, baicalin and (+)-catechin synergistically promoted the death of RAW267.4 cells. Such an effect was blocked by culture with caspase-3 inhibitor. The combination of the three agents decreased the protein levels of Akt, mitogen-activated protein kinase (MAPK) and cyclooxygenase (COX)-1 or -2. On the whole, this study demonstrates that the combination of beta-caryophyllene, baicalin and (+)-catechin exerts synergistic suppressive effects on macrophages in vitro. This composition may be a useful as an anti-inflammatory treatment strategy.
引用
收藏
页码:1940 / 1946
页数:7
相关论文
共 5 条
  • [1] Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro
    Yamaguchi, Masayoshi
    Levy, Robert M.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (02) : 1769 - 1774
  • [2] The combination of catechin, baicalin and -caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro
    Yamaguchi, Masayoshi
    Levy, Robert M.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (05) : 4312 - 4318
  • [3] Metaxalone Suppresses Production of Inflammatory Cytokines Associated with Painful Conditions in Mouse Macrophages RAW264.7 Cells in vitro: Synergistic Effect with β-caryophyllene
    Yamaguchi, Masayoshi
    Levy, Robert M.
    CURRENT MOLECULAR MEDICINE, 2020, 20 (08) : 643 - 652
  • [4] IL-33 synergistically promotes the proliferation of lung cancer cells in vitro by inducing antibacterial peptide LL-37 and proinflammatory cytokines in macrophages
    Jiang, Yinting
    Liao, Hongyi
    Zhang, Xuemei
    Cao, Sijia
    Hu, Xuexue
    Yang, Zihan
    Fang, Yuting
    Wang, Hong
    IMMUNOBIOLOGY, 2020, 225 (06)
  • [5] Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor-related apoptosis-inducing ligand-induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo
    Zhao, Xin
    Zhang, Cuicui
    Le, Zhiliang
    Zeng, Suyun
    Pan, Chaobin
    Shi, Jianjie
    Wang, Jianguang
    Zhao, Xiaopeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (03) : 1283 - 1294